Unknown

Dataset Information

0

NLRP3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture.


ABSTRACT: Sepsis is characterized by organ dysfunction due to a dysregulated immune response to infection. Currently, no effective treatment for sepsis exists. Platelets are recognized as mediators of the immune response and may be a potential therapeutic target for the treatment of sepsis. We previously demonstrated that NLRP3 inflammasome activation in sepsis-induced activated platelets was associated with multi-organ injury in the cecal-ligation puncture (CLP) rat model of sepsis. In this study, we tested the hypothesis that inhibition of NLRP3 would inhibit platelet activation and attenuate multi-organ injury in the CLP rat. CLP (n = 10) or Sham (n = 10) surgery were performed in male and female Sprague-Dawley rats. A subset of CLP rats were treated with MCC950 (50mg/kg/d), a specific NLRP3 inhibitor (CLP+MCC950, n = 10). At 72 hrs. post-CLP, blood and organs were harvested for analysis of platelet activation, NLRP3 activation, inflammation and end organ damage. Platelet activation increased from 8±0.8% in Sham to 16±1% in CLP, and was reduced to 9±1% in CLP+M rats (p<0.05). NLRP3 activation was also increased in platelets of CLP vs Sham. NLRP3 expression was unchanged in kidney and lung after CLP, but Caspase 1 expression and IL-1? were increased. MCC950 treatment attenuated NLRP3 activation in platelets. Plasma, kidney, and lung levels of NLRP3 inflammasome associated cytokines, IL-1ß and IL-18, were significantly increased in CLP compared to Sham rats. Inhibition of NLRP3 normalized cytokine levels. Glomerular injury, pulmonary edema, and endothelial dysfunction markers were increased in CLP rats vs Sham. MCC950 treatment significantly decreased renal and pulmonary injury and endothelial dysfunction in CLP+M. Our results demonstrate a role for NLRP3 in contributing to platelet activation and multi-organ injury in sepsis.

SUBMITTER: Cornelius DC 

PROVIDER: S-EPMC7299389 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

NLRP3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture.

Cornelius Denise C DC   Travis Olivia K OK   Tramel Robert W RW   Borges-Rodriguez Marivee M   Baik Cedar H CH   Greer Mallory M   Giachelli Chelsea A CA   Tardo Geilda A GA   Williams Jan M JM  

PloS one 20200617 6


Sepsis is characterized by organ dysfunction due to a dysregulated immune response to infection. Currently, no effective treatment for sepsis exists. Platelets are recognized as mediators of the immune response and may be a potential therapeutic target for the treatment of sepsis. We previously demonstrated that NLRP3 inflammasome activation in sepsis-induced activated platelets was associated with multi-organ injury in the cecal-ligation puncture (CLP) rat model of sepsis. In this study, we tes  ...[more]

Similar Datasets

| S-EPMC8184233 | biostudies-literature
| S-EPMC3813489 | biostudies-literature
2015-05-15 | GSE47094 | GEO
| S-EPMC5485362 | biostudies-other
2015-05-15 | E-GEOD-47094 | biostudies-arrayexpress
| S-EPMC7498613 | biostudies-literature
| S-EPMC5718978 | biostudies-literature
| S-EPMC3814834 | biostudies-other
| S-EPMC5863333 | biostudies-literature
| S-EPMC4653757 | biostudies-other